Skip to content

Study · Not a test of the peptide alone · 1991

1 result

[The effect of immunocorrective therapy on immunity in patients with idiopathic autoimmune cytopenias].

Tishchenko LM

Vrachebnoe delo1 Aug 1991

PMID1949738 (opens in a new tab)PepBankPUB-01949738
Publisher pageAsk about this study
Jump to 1 result

Summary

The text of this summary is not shown here, because the article license does not allow reuse. Read it at the source (opens in a new tab)

Text rights: Publisher copyright. Results still quote short attributed sentences.

Results from this study1

No result from this study comes from a test of the peptide.

Studies that did not test the peptide alone1

In this study, Thymalin was a lab tool or a carrier, part of a mix, or the subject of a lab method. These results are not evidence about taking Thymalin.

  1. 01HumanNot a test of Thymalin aloneNon-randomized trialEfficacy outcome

    In patients with idiopathic autoimmune cytopenias, the treatment scheme involving thymalin and glucocorticoids favored correction of immune system disorders.

    In plain wordsIn patients with autoimmune cytopenias, the treatment scheme involving thymalin and glucocorticoids helped correct immune system disorders.

    Peptide
    Thymalin
    Outcome
    Direction not reportedImmune system disorders
    Study

    n = 25

    Outcome group
    Immune response · Immune and inflammation

    Source sentences

    Summary
    It was established that the treatment favoured correction of disorders of the immune system characteristic of this kind of pathology.
    1 context sentence
    Summary · context
    The author studied the effect of immunostimulating (thymalin) and immunodepressive agents (glucocorticoids) on the state of the immune system in 25 patients with idiopathic autoimmune cytopenias.

    In this study, Thymalin was a lab tool or a carrier, part of a mix, or the subject of a lab method. This result is not evidence about taking Thymalin.

AI wrote and checked these results. AI can make mistakes, so check important results against the source.

Version history

PepBank keeps every version of the data on this study. Status changes from Retraction Watch, Europe PMC and Crossref are listed with their source.

  1. Version 2Current

    14 Oct 2026, 05:02 UTC

    Study results updated

  2. Version 1

    14 Oct 2026, 01:46 UTC

    First added · source update from Europe PMC

Subjects

Terms as the source lists them.

PepBank is a research reference. Talk to a doctor before you use any peptide.